Boehringer Ingelheim Archives - Page 2 of 7

Boehringer files for new rare disease use for nintedanib in EU, US

https://pharmaphorum.com/news/boehringer-files-for-new-rare-disease-use-for-nintedanib-in-eu-us/

AZ backs diabetes drug Farxiga with new cardio analysis

https://pharmaphorum.com/news/az-backs-diabetes-drug-farxiga-with-new-cardio-analysis/

Boehringer follows Sanofi with job cuts in France

https://pharmaphorum.com/news/boehringer-follows-sanofi-with-job-cuts-in-france/

Boehringer Ingelheim axes biosimilars development outside US

https://pharmaphorum.com/news/boehringer-ingelheim-axes-biosimilars-development-outside-us/

Google Ventures leads $45.4m investment in UK exosome biotech Evox

https://pharmaphorum.com/news/google-ventures-leads-45-4m-investment-in-uk-exosome-biotech-evox/

Boehringer joins UK academics in battle against cystic fibrosis

https://pharmaphorum.com/news/boehringer-battles-against-cystic-fibrosis/

BI to trial SIRP drug with in-house PD-1 inhibitor

https://pharmaphorum.com/news/bi-to-trial-sirp-drug-with-in-house-pd-1-inhibitor/

Boehringer Ingelheim rolls-out COPD digital adherence programme

https://pharmaphorum.com/news/boehringer-copd-digital-adherence/

Boehringer pins hopes on novel psoriasis drug

https://pharmaphorum.com/news/boehringer-pins-hopes-on-novel-psoriasis-drug/

Search